Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000191966 | SCV000657532 | uncertain significance | Brown-Vialetto-Van Laere syndrome 1 | 2017-07-25 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine with valine at codon 312 of the SLC52A3 protein (p.Ala312Val). The alanine residue is moderately conserved and there is a small physicochemical difference between alanine and valine. This variant is present in population databases (rs752218005, ExAC 0.004%). This variant has been reported in combination with another SLC52A3 variant in an individual affected with Brown–Vialetto–Van Laere syndrome (PMID: 2218020). ClinVar contains an entry for this variant (Variation ID: 210021). Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV000191966 | SCV000246221 | pathogenic | Brown-Vialetto-Van Laere syndrome 1 | 2015-03-17 | no assertion criteria provided | literature only |